Takayuki Mizutani
Directeur/Membre du Conseil chez Theoria Science KK
Profil
Takayuki Mizutani is currently the Representative Director at Theoria Science KK.
Previously, he worked as the Director of Business Development at B-Bridge International, Inc. He completed his graduate degree at California State University-Chico and his undergraduate degree at The Ohio State University.
Postes actifs de Takayuki Mizutani
| Sociétés | Poste | Début |
|---|---|---|
Theoria Science KK
 Theoria Science KK BiotechnologyHealth Technology Theoria Science KK is a company founded in 2012 and based in Tokyo, Japan. The Japanese company specializes in exosome research and offers the latest clinical knowledge and expertise in the field. Theoria Science is focused on developing early detection methods and therapeutic drugs for various diseases, including blood cancer. The company also provides medical services related to exosome research, such as early risk detection tests. | Directeur/Membre du Conseil | 01/01/2014 |
Anciens postes connus de Takayuki Mizutani
| Sociétés | Poste | Fin |
|---|---|---|
B-Bridge International, Inc.
 B-Bridge International, Inc. BiotechnologyHealth Technology B-Bridge International, Inc. manufactures biological products. It offers antibodies synthetic substitutes, cells, general reagents, IHC staining reagents, instruments, and kinase inhibitors. The company was founded by Hiroyuki Masumoto in 2000 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | - |
Formation de Takayuki Mizutani
| California State University-Chico | Graduate Degree |
| The Ohio State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
B-Bridge International, Inc.
B-Bridge International, Inc. BiotechnologyHealth Technology B-Bridge International, Inc. manufactures biological products. It offers antibodies synthetic substitutes, cells, general reagents, IHC staining reagents, instruments, and kinase inhibitors. The company was founded by Hiroyuki Masumoto in 2000 and is headquartered in Santa Clara, CA. | Health Technology |
Theoria Science KK
Theoria Science KK BiotechnologyHealth Technology Theoria Science KK is a company founded in 2012 and based in Tokyo, Japan. The Japanese company specializes in exosome research and offers the latest clinical knowledge and expertise in the field. Theoria Science is focused on developing early detection methods and therapeutic drugs for various diseases, including blood cancer. The company also provides medical services related to exosome research, such as early risk detection tests. | Health Technology |
